Editorial: Swift or sure?: The acceptable rate of neurovascular mimics among IV tPA-treated patients

Neurology

Volumn 74, Issue 17, 2010, Pages 1336-1337

  Saver, Jeffrey L ^a   Barsan, William G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONVERSION DISORDER; DRUG EFFICACY; DRUG SAFETY; EARLY DIAGNOSIS; EDITORIAL; FIBRINOLYTIC THERAPY; HEMIPARESIS; HUMAN; MIGRAINE; NEUROLOGICAL COMPLICATION; PARESIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEIZURE; DIFFERENTIAL DIAGNOSIS; NOTE;

BRAIN ISCHEMIA; DIAGNOSIS, DIFFERENTIAL; FIBRINOLYTIC AGENTS; HUMANS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 77951752207     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181dbe0ad     Document Type: Editorial

References (10)

1. Lyden PD. Extending the time window for thrombolytic therapy: primum non tardare. Lancet Neurol 2009;8: 1074-1075.
2. Latchaw RE, Alberts MJ, Lev MH, et al. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke 2009;40:3646-3678.
3. NINDS t-PA Stroke Study Investigators. NINDS t-PA Stroke Study Data Set [CD-ROM]. 2006. Available for purchase at: www.ntis.gov.
4. Chernyshev OY, Martin-Schild S, Albright KC, et al. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology 2010;74:1340-1345.
5. Hemmen TM, Meyer BC, McClean TL, Lyden PD. Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center. J Stroke Cerebrovasc Dis 2008;17:23-25.
6. Winkler DT, Fluri F, Fuhr P, et al. Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome. Stroke 2009;40:1522-1525.
7. Uchino K, Massaro L, Hammer MD. Transient isch-emic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy? Cerebrovasc Dis 2010;29:57-61.
8. Scott PA, Silbergleit R. Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes. Ann Emerg Med 2003;42:611-618. (Pubitemid 37329015)
9. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field: prospective validation of the Los Angeles Prehospital Stroke Screen (LAPSS). Stroke 2000;31:71-76. (Pubitemid 30035755)
10. Nor AM, Davis J, Sen B, et al. The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument. Lancet Neurol 2005;4:727-734. (Pubitemid 41457288)